~132 spots leftby Apr 2026

Pulmonary Function Testing for Neonatal Respiratory Disorders

(PUFFOR Trial)

TM
CP
Overseen ByColm P Travers, MD
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Alabama at Birmingham
Disqualifiers: Major malformation, Neuromuscular condition, Terminal illness, others
No Placebo Group
Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial uses a new device to measure lung function in newborns by sending gentle airwaves into their lungs while they breathe normally. It targets term and preterm infants, especially those with lung diseases, because traditional methods are difficult and often require sedation. This method is easier and safer for measuring lung function in newborns.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Non-invasive forced airway oscillometry for neonatal respiratory disorders?

Research shows that techniques like impulse oscillometry, which are part of the treatment, are effective in measuring lung function in children with conditions like asthma and cystic fibrosis. These methods are non-invasive, require minimal cooperation, and are sensitive in detecting changes in small airways, making them suitable for young children and potentially effective for neonatal respiratory disorders.12345

Is pulmonary function testing using oscillometry safe for humans?

Pulmonary function testing using oscillometry, which includes techniques like forced oscillation and impulse oscillometry, is generally considered safe for humans. It is non-invasive, requires minimal patient cooperation, and is suitable for young children and those unable to perform traditional lung function tests.12467

How is non-invasive forced airway oscillometry different from other treatments for neonatal respiratory disorders?

Non-invasive forced airway oscillometry is unique because it requires minimal patient cooperation and is more sensitive in detecting changes in small airways compared to traditional pulmonary function tests. This makes it particularly useful for infants who cannot perform standard tests due to their age or condition.1891011

Research Team

NA

Namasivayam Ambalavanan, MD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for infants born at or after 22 weeks of gestation who are off ventilators for at least 12 hours. It's open to those whose parents or guardians consent, but not to babies with terminal illnesses, neuromuscular conditions affecting breathing, major malformations, or if there's a decision to limit support.

Inclusion Criteria

My infant has been off a ventilator or CPAP for at least 12 hours.
My child's legal guardians have agreed to the study.
My baby was born at or after 22 weeks of pregnancy.

Exclusion Criteria

My infant has a significant birth defect.
A decision has been made to limit or not provide further treatment for my infant.
My infant has a condition that impacts their breathing.
See 1 more

Treatment Details

Interventions

  • Non-invasive forced airway oscillometry (Procedure)
Trial OverviewThe study observes lung function in newborns using non-invasive forced oscillometry. It aims to understand respiratory health in term and preterm infants with various lung diseases and how they respond to treatments without the need for invasive procedures.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Non-invasive forced airway oscillometryExperimental Treatment1 Intervention
Analyze lung function using forced airway oscillometry in preterm infants and term infants with and without lung disease with both cross-sectional and longitudinal comparisons. Aim 1: Lung function in term and preterm infants without lung disease (anticipated n=264) Aim 2: Lung function in preterm infants with respiratory distress syndrome (RDS) who develop bronchopulmonary dysplasia (BPD) and preterm infants with RDS who do not develop BPD (anticipated n=264) Aim 3: Lung function measurements in infants with common neonatal lung diseases (including RDS, BPD, meconium aspiration syndrome, and transient tachypnea of the newborn) and controls without lung disease (anticipated n=570) Aim 4: Lung function in infants with lung disease before and after common therapeutic interventions

Non-invasive forced airway oscillometry is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Impulse oscillometry for:
  • Assessment of lung function in preterm infants
  • Diagnosis of respiratory diseases such as bronchopulmonary dysplasia

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Findings from Research

Respiratory oscillometry is a valuable pulmonary function test that can be performed with minimal patient cooperation, making it suitable for young children and those unable to perform traditional spirometry due to cognitive or physical limitations.
After implementing a formal training program and standard operating protocol for respiratory oscillometry, there was a significant improvement in the quality of tests, leading to more acceptable and reproducible measurements, which is crucial for accurate lung function assessment.
Conducting Respiratory Oscillometry in an Outpatient Setting.Chang, E., Vasileva, A., Nohra, C., et al.[2023]
Impulse oscillometry is a useful technique for assessing asthma control in children aged 5-15 years, especially for those who cannot perform spirometry, as it is less dependent on patient effort.
Both impulse oscillometry and spirometry provide comparable information for monitoring asthma control, with specific parameters like FEV1 and area of reactance (AX) showing significant associations with controlled asthma over time.
Role of Impulse Oscillometry in Assessing Asthma Control in Children.Dawman, L., Mukherjee, A., Sethi, T., et al.[2020]
Impulse oscillometry (IOS) effectively distinguishes between asthmatic and non-asthmatic children, showing a significant bronchodilator response that correctly identified 77% of asthma cases in a study of 117 children.
IOS is a non-invasive method that can be used alongside or as an alternative to spirometry for assessing lung function in children, as it provides objective measurements of lung impedance without the variability seen in spirometry.
A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry.Komarow, HD., Skinner, J., Young, M., et al.[2022]

References

Conducting Respiratory Oscillometry in an Outpatient Setting. [2023]
Role of Impulse Oscillometry in Assessing Asthma Control in Children. [2020]
A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry. [2022]
Use of the forced oscillation technique to detect bronchodilation in children: experience from the Schneider Children's Medical Center of Israel. [2013]
Evaluation of children with cystic fibrosis by impulse oscillometry when stable and at exacerbation. [2018]
The Influence of Different Mouthpieces on Impulse Oscillometry Results. [2018]
Characteristics of inspiratory and expiratory reactance in interstitial lung disease. [2013]
Pulmonary function testing in the critically ill neonate, Part I: An overview. [2004]
Pulmonary function testing in the critically ill neonate, Part II: Methodology. [2004]
[Diagnosis of lung function in intensive care of newborn infants]. [2006]
11.United Statespubmed.ncbi.nlm.nih.gov
Measurement of respiratory function by impulse oscillometry in horses. [2019]